| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.32 | 2e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |